← Open Payments lookup

DEEPIKA SRINIVASAN: Open Payments

NPI 1811133762 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,298 in 57 payments from 10 companies in 2025. Trend: 2023 $523 · 2024 $1,173 · 2025 $2,298

Consulting: $1,245Food & beverage: $1,053
CompanyPaymentsAmount
Janssen Biotech, Inc.12$1,495
PFIZER INC.19$240
ABBVIE INC.10$143
Lilly USA, LLC4$105
Janssen Scientific Affairs, LLC1$71
Aimmune Therapeutics, Inc.4$65
Ardelyx, Inc.3$63
Novartis Pharmaceuticals Corporation1$60
Celltrion USA Inc.2$31
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24

Products named: TREMFYA, VELSIPITY, OMVOH, ZENPEP, LINZESS, IBSRELA, Fabhalta, MAVYRET.

Industry payments across TX — which companies pay providers there.